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The observations by Bakhtiyari and Mansournia on our
study [1] were received with great interest. We believe our
study was consistent with a case-control format [2]. In partic-
ular, our target population was selected from subjects diag-
nosed with diabetic foot ulcer (DFU) at the local high-risk
foot clinic, effectively fulfilling the criteria of control (DFU
without amputations) and case (DFU with amputation), as
previously described [3]. The identified risk factors were
computed amongst those with and without limb amputa-
tions. We do not believe our study was cross-sectional, being
retrospective in design, and it was not conducted at a specific
point in time rather for a period from January 2011 to
December 2013; both are in agreement with the definition
of a case-control study [4]. The prevalence of diabetic limb
amputation quoted in our study was for our high-risk dia-
betic foot clinic and not for the general population of North
Eastern Australia which was clearly outlined in the title as
clinic-based [5]. Interestingly, in line with Bakhtiyari’s and
Mansournia’s observation of a case-control study, our sam-
pling was based on the outcome (amputation) and was known
in advance prior to conducting the study [3]. Furthermore, in
keeping with a case-control study, we did not undertake
propensity matching since cases and controls were outcomes
rather than exposures [4]. With respect to our discussion on
the prevalence of diabetic limb amputation, comparing
clinic-based and non-clinic-based studies, the point was noted
but we clearly stated our study was similar to those reported by
others [6]. Overall, we do not think the title of our article was
confusing since it tallied with the methodology and content of
the article.
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